Universal Health Services (UHS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
9 Apr, 2026Executive summary
The annual meeting is scheduled for May 20, 2026, and will be held virtually, allowing all shareholders to participate online regardless of location.
Shareholders will vote on the election of directors, executive compensation, auditor ratification, and two shareholder proposals.
The Board recommends voting for the director nominees, executive compensation, and auditor ratification, and against both shareholder proposals.
Voting matters and shareholder proposals
Election of one director by Class A/C and one by Class B/D Common Stock, each for a three-year term.
Advisory (nonbinding) vote on named executive officer compensation (say-on-pay).
Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year 2026.
Shareholder proposal to report votes based on shareholder money at risk; Board recommends against.
Shareholder proposal to require public disclosure of workforce diversity; Board recommends against.
Board of directors and corporate governance
Board consists of seven members, divided into three classes, with a mix of management and independent directors.
Board has refreshed 80% of non-management members in the last eight years and includes three women, one from an underrepresented minority.
Four of seven directors are independent; Board committees are fully independent.
Board leadership includes an Executive Chairman and a Lead Independent Director.
Standing committees include Audit, Compensation, Nominating & Governance, Quality and Compliance, Executive, and Finance.
Latest events from Universal Health Services
- Strong 2025 results and 2026 growth outlook, with ongoing investment and managed regulatory risks.UHS
Q4 20259 Jul 2026 - Q2 2025 net income up 22% with strong revenue, margin gains, and higher EPS guidance amid Medicaid risks.UHS
Q2 20258 Jul 2026 - Q1 2025 net income rose 21% on 6.7% revenue growth, with strong segment performance.UHS
Q1 20258 Jul 2026 - Strong 2024 performance, margin recovery, and behavioral growth drive optimism despite policy headwinds.UHS
KeyBanc Annual Healthcare Forum 20258 Jul 2026 - AI, outpatient growth, and capital deployment drive margin and volume strategies for 2026.UHS
Goldman Sachs 47th Annual Global Healthcare Conference 20269 Jun 2026 - Directors and auditors were approved; shareholder proposal on voting structure was rejected.UHS
AGM 202620 May 2026 - Revenue growth, operational expansion, and AI-driven efficiency shape a positive outlook.UHS
Bank of America Global Healthcare Conference 202618 May 2026 - Q1 2026 delivered strong growth, Talkspace acquisition, and Medicaid headwinds ahead.UHS
Q1 20267 May 2026 - Virtual annual meeting to vote on director, pay, auditor, and ESG-related proposals.UHS
Proxy filing9 Apr 2026